Skip to main content
NVDA+0.97%AAPL-1.16%GOOGL-1.32%MSFT-1.27%AMZN-1.67%TSM-0.50%SPCX-1.78%META+0.19%AVGO-0.66%TSLA-0.10%SKHY+1.76%BRK-B+0.01%LLY+0.80%MU+1.72%JPM-0.76%WMT-0.04%AMD+2.94%V-0.54%XOM+1.31%JNJ-1.04%ASMLa-1.00%0700.HK+1.90%MA-1.11%INTC+1.82%ABBV-0.14%1398.HK-2.09%CSCO+0.56%CVX+1.29%BAC-0.06%ORCL-1.40%COST-1.07%KO-0.85%CAT-0.28%DELL+4.27%HSBA.L-0.81%0005.HK-3.21%UNH-1.52%PG+0.14%LRCX-1.78%AP2d-2.04%AMAT-0.96%NFLX-3.18%GE-2.12%MS-2.08%1816.HK-0.46%3988.HK-2.13%0857.HK+0.60%HD-1.27%PM-0.89%0939.HK-2.83%NZDUSD-1.03%USDJPY+0.89%GBPNZD+0.80%USDTHB+0.73%NZDCAD-0.69%NZDCHF-0.64%GBPJPY+0.62%AUDUSD-0.61%CHFJPY+0.59%CADJPY+0.55%EURNZD+0.55%EURUSD-0.49%AUDNZD+0.43%NZDMXN-0.42%GBPTRY+0.41%USDCHF+0.39%EURJPY+0.37%GBPAUD+0.35%USDCAD+0.34%GBPHKD+0.32%AUDJPY+0.30%PLNJPY+0.29%NOKJPY+0.29%GBPMXN-0.28%AUDCAD-0.25%NZDSGD-0.25%USDTRY+0.25%GBPUSD-0.24%USDSEK+0.23%EURGBP-0.22%AUDCHF-0.21%SGDJPY+0.20%CHFNOK-0.19%USDSGD+0.18%EURCAD-0.18%EURSEK+0.16%USDILS+0.16%NZDJPY-0.14%EURAUD+0.13%GBPCHF+0.12%GBPSGD+0.12%EURSGD+0.12%AUDDKK-0.11%EURCZK+0.11%CHFSGD-0.10%GBPCAD+0.10%USDNOK+0.10%USDPLN+0.09%EURCHF-0.08%AUDNOK-0.08%USDCNH+0.08%EURZAR-0.07%GBPZAR-0.07%CHFSEK-0.06%USDDKK+0.06%EURHKD-0.05%USDCOP-0.04%CADCHF+0.04%EURNOK+0.03%EURPLN+0.02%USDHKD+0.02%USDMXN+0.01%USDZAR-0.01%AUDSGD+0.01%EURCNH-0.01%EURDKK-0.01%USOIL+2.27%UKOIL+1.54%W1+1.02%COFFEE-0.91%XNGUSD+0.83%C1+0.61%S1+0.58%HG1+0.46%SUGAR-0.39%XAUUSD-0.37%GAUUSD-0.37%COTTON-0.31%BTCUSD-2.75%ETHUSD-3.62%USDTUSD-0.04%XRPUSD-2.02%SOLUSD-2.95%TRXUSDT-0.27%ZECUSDT-3.62%DOGEUSD-1.89%XMRUSDT+0.62%LINKUSD-2.20%XLMUSD+0.91%BCHUSDT-0.76%UNIUSD-3.18%LTCUSD-2.06%HBARUSDT-0.30%TONUSD+26.79%SUIUSD-2.29%TAOUSDT-3.70%AAVEUSD-1.77%DOTUSDT-2.01%ICPUSDT-7.39%ONDOUSDT-3.26%WLDUSDT-1.56%ARBUSDT+3.65%ATOMUSDT-1.91%JUPUSDT-4.72%INJUSDT-6.53%STXUSDT-2.35%FETUSDT-3.83%PYTHUSDT-4.13%TIAUSDT-4.46%SEIUSDT-2.47%IMXUSDT-1.81%OPUSDT-2.68%GRTUSDT-3.80%WIFUSDT-4.80%POLUSDT+0.22%IOTAUSDT-5.28%AXSUSDT-3.31%FARTCOINUSDT-1.50%EOSUSDT-3.48%DYDXUSDT-5.87%ORDIUSDT-1.75%GALAUSDT-1.47%NOTUSDT-0.18%RONINUSDT-4.03%NVDA+0.97%AAPL-1.16%GOOGL-1.32%MSFT-1.27%AMZN-1.67%TSM-0.50%SPCX-1.78%META+0.19%AVGO-0.66%TSLA-0.10%SKHY+1.76%BRK-B+0.01%LLY+0.80%MU+1.72%JPM-0.76%WMT-0.04%AMD+2.94%V-0.54%XOM+1.31%JNJ-1.04%ASMLa-1.00%0700.HK+1.90%MA-1.11%INTC+1.82%ABBV-0.14%1398.HK-2.09%CSCO+0.56%CVX+1.29%BAC-0.06%ORCL-1.40%COST-1.07%KO-0.85%CAT-0.28%DELL+4.27%HSBA.L-0.81%0005.HK-3.21%UNH-1.52%PG+0.14%LRCX-1.78%AP2d-2.04%AMAT-0.96%NFLX-3.18%GE-2.12%MS-2.08%1816.HK-0.46%3988.HK-2.13%0857.HK+0.60%HD-1.27%PM-0.89%0939.HK-2.83%NZDUSD-1.03%USDJPY+0.89%GBPNZD+0.80%USDTHB+0.73%NZDCAD-0.69%NZDCHF-0.64%GBPJPY+0.62%AUDUSD-0.61%CHFJPY+0.59%CADJPY+0.55%EURNZD+0.55%EURUSD-0.49%AUDNZD+0.43%NZDMXN-0.42%GBPTRY+0.41%USDCHF+0.39%EURJPY+0.37%GBPAUD+0.35%USDCAD+0.34%GBPHKD+0.32%AUDJPY+0.30%PLNJPY+0.29%NOKJPY+0.29%GBPMXN-0.28%AUDCAD-0.25%NZDSGD-0.25%USDTRY+0.25%GBPUSD-0.24%USDSEK+0.23%EURGBP-0.22%AUDCHF-0.21%SGDJPY+0.20%CHFNOK-0.19%USDSGD+0.18%EURCAD-0.18%EURSEK+0.16%USDILS+0.16%NZDJPY-0.14%EURAUD+0.13%GBPCHF+0.12%GBPSGD+0.12%EURSGD+0.12%AUDDKK-0.11%EURCZK+0.11%CHFSGD-0.10%GBPCAD+0.10%USDNOK+0.10%USDPLN+0.09%EURCHF-0.08%AUDNOK-0.08%USDCNH+0.08%EURZAR-0.07%GBPZAR-0.07%CHFSEK-0.06%USDDKK+0.06%EURHKD-0.05%USDCOP-0.04%CADCHF+0.04%EURNOK+0.03%EURPLN+0.02%USDHKD+0.02%USDMXN+0.01%USDZAR-0.01%AUDSGD+0.01%EURCNH-0.01%EURDKK-0.01%USOIL+2.27%UKOIL+1.54%W1+1.02%COFFEE-0.91%XNGUSD+0.83%C1+0.61%S1+0.58%HG1+0.46%SUGAR-0.39%XAUUSD-0.37%GAUUSD-0.37%COTTON-0.31%BTCUSD-2.75%ETHUSD-3.62%USDTUSD-0.04%XRPUSD-2.02%SOLUSD-2.95%TRXUSDT-0.27%ZECUSDT-3.62%DOGEUSD-1.89%XMRUSDT+0.62%LINKUSD-2.20%XLMUSD+0.91%BCHUSDT-0.76%UNIUSD-3.18%LTCUSD-2.06%HBARUSDT-0.30%TONUSD+26.79%SUIUSD-2.29%TAOUSDT-3.70%AAVEUSD-1.77%DOTUSDT-2.01%ICPUSDT-7.39%ONDOUSDT-3.26%WLDUSDT-1.56%ARBUSDT+3.65%ATOMUSDT-1.91%JUPUSDT-4.72%INJUSDT-6.53%STXUSDT-2.35%FETUSDT-3.83%PYTHUSDT-4.13%TIAUSDT-4.46%SEIUSDT-2.47%IMXUSDT-1.81%OPUSDT-2.68%GRTUSDT-3.80%WIFUSDT-4.80%POLUSDT+0.22%IOTAUSDT-5.28%AXSUSDT-3.31%FARTCOINUSDT-1.50%EOSUSDT-3.48%DYDXUSDT-5.87%ORDIUSDT-1.75%GALAUSDT-1.47%NOTUSDT-0.18%RONINUSDT-4.03%
AP

Agios Pharmaceuticals, Inc. (AGIO)

NASDAQ • Healthcare

$33.22
-$0.38 (-1.1%)
Market open

Last close at September 14, 2026 at 20:00 UTC

Open$33.83
Previous Close$33.22
Day Range$32.89 - $34.35
Avg. Volume (3M)837.2K
Market Cap$1.9B
52 Week Range
$22.24$46
Next EarningsIn 44 daysOct 29, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$44.7M100%
Gross Profitminus cost of goods$41.7M93%

Fundamentals & Financials

Revenue (TTM)
$98.3M
Net Income (TTM)
-$411.2M
EPS (TTM)
-$7.01
ROA (TTM)
-37.11%
Current Ratio
10.22

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+6.1%Q1 2026-$1.85
+6.6%Q2 2026-$1.69
-2.4%Q3 2026-$1.69
Next

Oct 29

in 44 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals, Inc. is a NASDAQ-listed biotechnology company focused on medicines and research programs that target cellular metabolism, with work centered on hemolytic anemias and related diseases. In FY2025, the company generated $54.0 million in revenue, with its business anchored by a commercial rare-disease medicine and an earlier-stage pipeline candidate.

Name
Agios Pharmaceuticals, Inc.
CEO
Brian Goff
Website
www.agios.com
Industry
Healthcare
Year Founded
2007
Employees
540

Today's Snapshot

AI-generated

AGIO ended yesterday 1.1% down at 33.22.

Trading Volume

Below 10d avg (791.0K)

717.5K

vs S&P 500 Today

Underperforming Market

-0.65%

Updated: September 15, 2026 at 12:28 UTC

Technical Indicators

1 Buy3 Neutral4 Sell
AGIO shows a weak directional bias with ADX near 10, indicating little trend conviction, while short-term momentum is negative and RSI sits slightly below neutral, reflecting mild selling pressure. The price trades under the 10‑ and 20‑period averages but remains above the 100‑ and 200‑day levels, so shorter-term moving averages are weighing on the action even as longer-term support holds. Volatility is moderate and recent ATR reading is about one and a half dollars, and on-balance volume tilts toward distribution. The pivot sits marginally above the market, reinforcing the cautious tone. Technical takeaway: Sell.
All signals
  • EMA (5 indicators)$33.03 - $33.89
    Sell
  • RSI (14)46.15
    Neutral
  • Stochastic %K (14, 3, 3)39.89
    Neutral
  • MACD Level (12, 26)-0.17
    Neutral

Peers & Related Assets

IBRXImmunityBio, Inc.
$8.37+5.8%
LQDALiquidia Corporation
$65.31-2.1%
COGTCogent Biosciences, Inc.
$33.410.0%
DNLIDenali Therapeutics Inc.
$21.22+0.6%
RCUSArcus Biosciences, Inc.
$24.07-2.1%
BEAMBeam Therapeutics Inc.
$24.12+0.5%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.